Is quantitative real time polymerase chain reaction MCAM transcript assay really suitable for prognostic and predictive management of melanoma patients?

Br J Dermatol. 2014 Jul;171(1):190-1. doi: 10.1111/bjd.12818. Epub 2014 Jun 22.

Authors

E Capoluongo¹, C Paolillo, F Vendittelli

Affiliation

¹ Laboratory of Clinical Molecular and Personalized Diagnostics, Policlinico A. Gemelli, Teaching Hospital, Largo F. Vito 1, 00136, Rome, Italy; Laboratory of Clinical Molecular and Personalized Diagnostics, Department of Biochemistry and Clinical Biochemistry, Catholic University, Rome, Italy.

PMID: 24397844
DOI: 10.1111/bjd.12818

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers, Tumor / blood*
Female
Humans
Male
Melanoma / pathology*
Neoplasm Recurrence, Local / pathology*
Neoplastic Cells, Circulating / pathology*
Skin Neoplasms / pathology*

Substances

Biomarkers, Tumor